Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays

Abstract INTRODUCTION We assessed the concordance of cerebrospinal fluid (CSF) amyloid beta (Aβ) and tau measured on the fully automated Lumipulse platform with pre‐symptomatic Alzheimer's disease (AD) pathology on amyloid positron emission tomography (PET). METHODS In 72 individuals from the Insigh...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Ashvini Keshavan, Henrietta Wellington, Zhongbo Chen, Ayesha Khatun, Miles Chapman, Melanie Hart, David M. Cash, William Coath, Thomas D. Parker, Sarah M. Buchanan, Sarah E. Keuss, Matthew J. Harris, Heidi Murray‐Smith, Amanda Heslegrave, Nick C. Fox, Henrik Zetterberg, Jonathan M Schott
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2021-01-01
coleção:	Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Assuntos:	amyloid cerebrospinal fluid Lumipulse positron emission tomography tau
Acesso em linha:	https://doi.org/10.1002/dad2.12131
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!